Eva C. Boratto Sells 8,130 Shares of CVS Health Corp (NYSE:CVS) Stock

CVS Health Corp (NYSE:CVS) CFO Eva C. Boratto sold 8,130 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $65.00, for a total transaction of $528,450.00. Following the transaction, the chief financial officer now owns 55,273 shares in the company, valued at $3,592,745. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Shares of CVS stock traded up $0.16 during mid-day trading on Friday, reaching $64.06. 6,183,864 shares of the company were exchanged, compared to its average volume of 10,824,508. CVS Health Corp has a fifty-two week low of $51.72 and a fifty-two week high of $82.15. The company has a debt-to-equity ratio of 1.39, a quick ratio of 0.64 and a current ratio of 0.95. The company has a market capitalization of $82.71 billion, a P/E ratio of 9.05, a P/E/G ratio of 1.39 and a beta of 0.85. The business’s 50 day simple moving average is $59.26 and its 200 day simple moving average is $55.85.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.70 by $0.19. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The business had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. During the same quarter last year, the company earned $1.69 earnings per share. The business’s quarterly revenue was up 35.2% compared to the same quarter last year. On average, analysts forecast that CVS Health Corp will post 6.96 EPS for the current year.

CVS has been the topic of several recent analyst reports. Morgan Stanley reiterated a “buy” rating and set a $74.00 price objective on shares of CVS Health in a report on Sunday, August 11th. Standpoint Research upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Wednesday, June 5th. Bank of America increased their price objective on shares of CVS Health from $72.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday. Evercore ISI set a $63.00 target price on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Finally, Citigroup increased their target price on shares of CVS Health from $68.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. CVS Health currently has an average rating of “Buy” and an average price target of $75.91.

Several hedge funds have recently added to or reduced their stakes in CVS. Mutual Advisors LLC lifted its stake in CVS Health by 0.8% in the second quarter. Mutual Advisors LLC now owns 20,641 shares of the pharmacy operator’s stock valued at $1,125,000 after buying an additional 172 shares during the last quarter. Capital Investment Advisory Services LLC lifted its stake in CVS Health by 3.8% in the first quarter. Capital Investment Advisory Services LLC now owns 5,128 shares of the pharmacy operator’s stock valued at $277,000 after buying an additional 189 shares during the last quarter. Fiduciary Group LLC lifted its stake in CVS Health by 3.2% in the second quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock valued at $353,000 after buying an additional 200 shares during the last quarter. First Command Financial Services Inc. lifted its stake in CVS Health by 16.0% in the second quarter. First Command Financial Services Inc. now owns 1,464 shares of the pharmacy operator’s stock valued at $80,000 after buying an additional 202 shares during the last quarter. Finally, Hudock Capital Group LLC lifted its stake in CVS Health by 54.0% in the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 202 shares during the last quarter. 76.06% of the stock is owned by institutional investors and hedge funds.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: Certificate of Deposit (CD)

Insider Buying and Selling by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.